Kevin Outterson

Executive Director and Principal Investigator, CARB-X, Professor of Law, Boston University

Professor Outterson teaches health care law at Boston University, where he co-directs the Health Law Program. He serves as the founding executive director and principal investigator of CARB-X, a $480M international public-private partnership to accelerate global antibacterial innovation. His research focuses on the law and economics of antimicrobial resistance. He served as a senior author on many key research reports on antibiotic innovation, including Chatham House, ERG, DRIVE-AB, and the Lancet Commission. Professor Outterson received the 2015 Leadership Award by the Alliance for the Prudent Use of Antibiotics for his research and advocacy work. He has testified before the US Congress, UK Parliamentary working groups, World Health Organization, and state legislatures